These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8356936)

  • 1. Deflazacort in the treatment of uveitis: a comparative study versus prednisone.
    Cerqueti Piera M; Saccà Sergio C; Allegri P; Ciurlo G; Zingirian M; Buscaglia S; Ciprandi G
    Allergol Immunopathol (Madr); 1993; 21(3):107-10. PubMed ID: 8356936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary experience with deflazacort, a new synthetic steroid with fewer undesirable side effects, in heart transplant patients.
    Arizón JM; Anguita M; Vallés F; Montero A; Sancho M; López-Rubio F; Latre JM; Calleja F; Casares J; Román M
    J Heart Lung Transplant; 1993; 12(3):445-8; discussion 448-9. PubMed ID: 8329416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prednisone versus deflazacort in the treatment of autoimmune thrombocytopenic purpura: evaluation of clinical response and immunological modifications.
    Ferrari A; Pasqualetti D; Del Bianco P; Gandolfo GM; Chistolini A; Mazzucconi MG
    Haematologica; 1991; 76(4):342-5. PubMed ID: 1794742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized study comparing deflazacort and prednisone in heart transplant patients.
    Arizón JM; Anguita M; Vallés F; López-Rubio F; López-Granados A; Casares J; Segura J; Mesa D; Muñoz I; Alados P
    J Heart Lung Transplant; 1993; 12(5):864-8. PubMed ID: 8241229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deflazacort for long-term maintenance of remission in type I autoimmune hepatitis.
    Rebollo Bernárdez J; Cifuentes Mimoso C; Piñar Moreno A; Caunedo Alvarez A; Salas Herrero E; Jiménez-Sáenz M; Herrerías Gutiérrez J
    Rev Esp Enferm Dig; 1999 Sep; 91(9):630-8. PubMed ID: 10502711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term therapy with the new glucocorticosteroid deflazacort in rheumatoid arthritis. Double-blind controlled randomized 12-months study against prednisone.
    Eberhardt R; Krüger K; Reiter W; Gross W; Zwingers T
    Arzneimittelforschung; 1994 May; 44(5):642-7. PubMed ID: 8024639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
    Cacoub P; Chemlal K; Khalifa P; Wechsler B; De Gennes C; Belmatoug N; Cohen P; Ziza JM; Verdoncq B; Piette JC
    J Rheumatol; 2001 Nov; 28(11):2474-9. PubMed ID: 11708421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of hydrocortisone versus deflazacort in drug-resistant epilepsy of childhood.
    Grosso S; Farnetani M; Mostardini R; Cordelli D; Berardi R; Balestri P
    Epilepsy Res; 2008 Sep; 81(1):80-5. PubMed ID: 18524542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deflazacort in thrombocytopenia: a comparison with prednisone.
    Mazzucconi MG; Malagnino F; De Laurentis C; Criscuolo D
    Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(12):538-42. PubMed ID: 7194867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: prednisone versus deflazacort.
    LoCascio V; Ballanti P; Milani S; Bertoldo F; LoCascio C; Zanolin EM; Bonucci E
    Calcif Tissue Int; 1998 Mar; 62(3):199-204. PubMed ID: 9501951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
    Moxley RT; Ashwal S; Pandya S; Connolly A; Florence J; Mathews K; Baumbach L; McDonald C; Sussman M; Wade C; ;
    Neurology; 2005 Jan; 64(1):13-20. PubMed ID: 15642897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compared clinical efficacy and bone metabolic effects of low-dose deflazacort and methyl prednisolone in male inflammatory arthropathies: a 12-month open randomized pilot study.
    Saviola G; Abdi Ali L; Shams Eddin S; Coppini A; Cavalieri F; Campostrini L; Sacco S; Bucci M; Cirino G; Rossini M
    Rheumatology (Oxford); 2007 Jun; 46(6):994-8. PubMed ID: 17384176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deflazacort. A review of its pharmacological properties and therapeutic efficacy.
    Markham A; Bryson HM
    Drugs; 1995 Aug; 50(2):317-33. PubMed ID: 8521761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the quality of life in kidney transplant patients: a randomized, double-blind comparison of Deflazacort and prednisone.
    Alvarez-Amador L; Alvarado-Vega AG; Zúñiga-Armendáriz V; Zaragoza RM; Diliz HS; Arce-Salinas CA
    Transplant Proc; 1996 Dec; 28(6):3391-3. PubMed ID: 8962324
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders.
    Gray RE; Doherty SM; Galloway J; Coulton L; de Broe M; Kanis JA
    Arthritis Rheum; 1991 Mar; 34(3):287-95. PubMed ID: 2003854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deflazacort versus 6-methylprednisolone in renal transplantation: immunosuppressive activity and side effects.
    Elli A; Rivolta R; Palazzi P; Mascaretti L; Puglisi G; Parenti M; Sioli V; Di Palo FQ
    Transplant Proc; 1990 Aug; 22(4):1689-90. PubMed ID: 2202126
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of the effectiveness of 2 oral corticoids in the control of severe crisis of bronchial asthma: deflazacort and prednisone].
    Chapela R
    Rev Alerg Mex; 1995; 42(4):64-8. PubMed ID: 7552187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroid effects on blood gene expression in Duchenne muscular dystrophy.
    Lit L; Sharp FR; Apperson M; Liu DZ; Walker WL; Liao I; Xu H; Ander BP; Wong B
    Pharmacogenomics J; 2009 Dec; 9(6):411-8. PubMed ID: 19488064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of remission in Wegener's granulomatosis with low dose methotrexate.
    de Groot K; Mühler M; Reinhold-Keller E; Paulsen J; Gross WL
    J Rheumatol; 1998 Mar; 25(3):492-5. PubMed ID: 9517769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of thyroid-associated ophthalmopathy: comparative study between prednisone and COP therapy].
    Min HY; Liu XP; Jiang RX; Lian L; Hu TS
    Zhonghua Yan Ke Za Zhi; 2005 Sep; 41(9):781-5. PubMed ID: 16191342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.